Medication info
Rosuvastatin Calcium 10mg Tablets

Rosuvastatin Calcium 10mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets (10 tablets/Alu-Alu X3)
Approval status
Active

MFDS item code 201400154 · Approved 2014.01.15 · Insurance code 648103340

Summary

Main use
Improves dyslipidemia, reduces the risk of cardiovascular disease, and inhibits the progression of atherosclerosis
Who takes it
Adults · Children
Adult dose
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of the day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: Dose adjustment is not required. 4. Patients with renal impairment: Dose adjustment is not required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Child dose
Ages 10 ~ 17 years: The usual dosage range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on administration of doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Improves dyslipidemia, reduces the risk of cardiovascular disease, and inhibits the progression of atherosclerosis

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • cardiovascular disease risk factors
  • stroke risk
  • myocardial infarction risk
  • risk of coronary artery revascularization
View approved original text

This medication is used as an adjunct therapy when diet and exercise do not adequately control primary hypercholesterolemia and mixed dyslipidemia. It can also be prescribed together with other treatments for patients with homozygous familial hypercholesterolemia. This drug helps lower total cholesterol and LDL cholesterol levels, thus delaying the progression of atherosclerosis. It is also used as an adjunctive agent to reduce total cholesterol and LDL cholesterol levels in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia. It is utilized as adjunctive therapy for patients with primary dysbetalipoproteinemia. Additionally, it contributes to reducing the risk of stroke, myocardial infarction, and coronary artery revascularization in middle-aged and older adults with cardiovascular disease risk factors. Overall, this medication is used to improve dyslipidemia and reduce the risk of related cardiovascular diseases.

How to take

Adult dose

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of the day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: Dose adjustment is not required. 4. Patients with renal impairment: Dose adjustment is not required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.

Child dose

Ages 10 ~ 17 years: The usual dosage range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on administration of doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be administered to certain patients. For instance, it should not be used in patients who are allergic to it, have severely impaired liver function, suffer from muscle diseases, have severely reduced kidney function, or are pregnant or breastfeeding. Additionally, it should be used with caution in cases where regular monitoring of liver function tests and muscle status is necessary. Particular care is needed for patients with a history of liver disease or high alcohol intake, those with hypothyroidism, elderly individuals over 70 years old, and those exhibiting muscle abnormal symptoms. If symptoms such as muscle pain, muscle weakness, fatigue, or fever occur during treatment, the physician should be notified immediately for evaluation. If such symptoms are severe or if there is a significant increase in muscle enzyme levels, discontinuation of the medication may be required. As this medication may affect liver function, usage must be stopped immediately if symptoms of liver dysfunction or jaundice, or severe fatigue occur. Furthermore, this medication can raise blood sugar levels, so patients at risk of diabetes should maintain strict blood sugar control. This medication may interact with other drugs, so it is crucial to inform your physician or pharmacist of any other medications being taken. Particularly, co-administration with certain antiviral agents, immunosuppressants, and fibrate drugs may increase the risk of muscle abnormalities. Women who are pregnant or planning a pregnancy must use appropriate contraception and should discontinue the medication immediately upon confirmation of pregnancy. Nursing mothers should also ideally avoid taking this medication. In the case of overdose, there is no specific antidote, and treatment is symptomatic while monitoring liver function and muscle enzyme levels. Finally, this medication may cause side effects such as dizziness or headaches, so caution is needed when driving or operating machinery.

Side effects

Angioedema, hypersensitivity reaction, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, morbilliform drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, memory impairment, forgetfulness, amnesic syndrome, cognitive dysfunction, confusion, ALT increase, chest pain, muscle cramp, gout, erectile dysfunction, AST increase, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it must be stored in a tightly closed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help keep the medication effective and safe for a long time.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets (10 tablets/Alu-Alu X3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.